Table 1 |
|||
|
Effects of various NO donors on stimulation evoked [3H]noradrenaline release and vasoconstriction in the rat tail arteries |
|||
|
Treatment |
n |
S4/S2 ratio |
|
|
[3H]noradrenaline |
Vasoconstriction |
||
|
|
|||
|
Control |
7 |
1.08 ± 0.05 |
1.04 ± 0.06 |
|
DNIC-cysteine 3 μM |
6 |
1.31 ± 0.06** |
0.25 ± 0.02** |
|
DNIC-thiosulfate 3 μM |
6 |
1.38 ± 0.07** |
0.33 ± 0.04** |
|
Fe(II)-thiosulfate 10 μM |
6 |
1.01 ± 0.03 |
0.92 ± 0.05 |
|
SNP 10 μM |
7 |
1.04 ± 0.04 |
0.27 ± 0.06** |
|
Cys-NO 10 μM |
7 |
1.08 ± 0.06 |
0.23 ± 0.02** |
|
GS-NO 10 μM |
7 |
1.01 ± 0.03 |
0.27 ± 0.02** |
|
|
|||
|
**P < 0.01 in comparison to control arteries. |
|||
|
Kleschyov et al. BMC Pharmacology 2002 2:3 doi:10.1186/1471-2210-2-3 |
|||